Courses

← vista completa

Published on November 1, 2002 | http://doi.org/10.5867/medwave.2002.10.3172

Telomerase in pediatric oncology

Telomerasa en la oncología pediátrica

Patricia Alvarez Aguayo

This work is licensed under a Creative Commons Attribution 4.0 International License. Esta licencia permite el uso, distribución y reproducción del artículo en cualquier medio, siempre y cuando se otorgue el crédito correspondiente al autor del artículo y al medio en que se publica, en este caso, Medwave.

Authors

Patricia Alvarez Aguayo

Facultad de Medicina, Universidad de Chile, Santiago, Chile

Figures

Article has no figures.

Forum

No messages

History

Citation Alvarez Aguayo P. Telomerase in pediatric oncology. Medwave 2002;2(10):e3172 doi: 10.5867/medwave.2002.10.3172

Submission date 01/01/1970

Acceptance date 01/01/1970

Publication date 01/11/2002

Index

Metrics

Not available at the moment.

Notes

References

  1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000 Jan 7;100(1):57-70. | CrossRef
  2. Shay JW, Wright WE and Werbin H. Defining the molecular mechanisms of human cell immortalization. Biochim Biophys Acta. 1991 Apr 16;1072(1):1-7. | PubMed
  3. Hahn WC, Counter CM, Lundberg AS, Beijersbergen RL, Brooks MW and Weinberg RA. Creation of human tumour cells with defined genetic elements. Nature. 1999 Jul 29;400(6743):464-8. | CrossRef | PubMed
  4. Vogelstein B and Kinzler KW. The multistep nature of cancer. Trends Genet. 1993 Apr;9(4):138-41. | CrossRef
  5. Wright WE and Shay JW. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med. 2000 Aug;6(8):849-51. | CrossRef | PubMed
  6. Buys Charles HCM. Telomeres, telomerase and cancer. N Engl J Med. 2000 Apr 27;342(17):1282-3 | CrossRef | PubMed
  7. Shay JW, Zou Y, Hiyama E and Wright WE. Telomerase and Cancer. Human Molecular Genetics, 10 (7), 677–685, 2001. | CrossRef | PubMed
  8. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965 Mar;37:614-36. | CrossRef
  9. Shay JW and Wright WE. Haylick, his limit, and cellular aging Nat Rev Mol Cell Biol. 2000 Oct;1(1):72-6. http://dx.doi.org/10.1038/35036093 | CrossRef | PubMed
  10. Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD, et al A highly conserved repetitive DNA sequence, (TTAGGG)©ú, present at the telomeres of human chromosomes. Proc Natl Acad Sci U S A. 1988 Sep;85(18):6622-6. | CrossRef
  11. Blackburn EH. The end of the (DNA) line. Nat Struct Biol. 2000 Oct;7(10):847-50. | CrossRef | PubMed
  12. Huffman KE, Levene SD, Tesmer VM, Shay JW, Wright WE. Telomere shortening is proportional to the size of the 3’ G – rich telomric overhang. J Biol Chem. 2000 Jun 30;275(26):19719-22. | CrossRef | PubMed
  13. Watson JD. Origin concatameric T4 DNA. Nat New Biol. 1972 Oct 18;239(94):197-201. | PubMed
  14. Olovnikov AM. A theory of marginotomy. The incomplete copying of template margin in enzymic synthesis of polynucleotides and biological significance of the phenomenon. J Theor Biol. 1973 Sep 14;41(1):181-90. | CrossRef
  15. Gavory G, Balasubramanian Sh, Krupp G, Parwaresch R. PNA and Oligonucleotide Inhibitors of human Telomerase En: Telomerases, telomeres, and cáncer. EE.UU. Georgetown,2002.
  16. Haber DA. Telomeres,cancer, and inmortality. N Engl J Med. 1995 Apr 6;332(14):955-6. | CrossRef | PubMed
  17. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, Killery AM,et al. Structure and variability of human chromosome ends. Mol Cell Biol. 1990 Feb;10(2):518-27. | PubMed
  18. Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC, Telomere reduction in human colorectal carcinoma and with ageing. Nature. 1990 Aug 30;346(6287):866-8. | CrossRef | PubMed
  19. Counter CM, Hirte HW, Bacchetti S, Harley CB. Telomerase activity in human ovarian carcinoma. Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):2900-4. | CrossRef
  20. Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL,et al. Specific association of human telomerase activity with inmortal cells and cancer. Science. 1994 Dec 23;266(5193):2011-5. | CrossRef | PubMed
  21. Shay JW, Bacchetti S. A survey of telomerase activity in human cancer. Eur J Cancer. 1997 Apr;33(5):787-91. | CrossRef
  22. Breslow RA, Shay JW, Gazdar AF, Srivastava S. Telomerase and early detection of cancer : a national cancer institute workshop. J Natl Cancer Inst. 1997 May 7;89(9):618-23. | CrossRef
  23. Shay JW. Telomerase in cancer : diagnostic, prognostic and therapeutic implications Cancer J Sci Am. 1998 May;4 Suppl 1:S26-34. | PubMed
  24. Norton JC, Holt SE, Wright WE, Shay JW. Enhanced detection of telomerase activity in tumor derived human cell lines. DNA Cell Biol. 1998 Mar;17(3):217-9. | CrossRef | PubMed
  25. Hiyama E, Hiyama K, Yokoyama T, Matsuura Y, Piatyszek MA, Shay JW. Correlating telomerase activity levels with human neuroblastoma outcomes. Nat Med. 1995 Mar;1(3):249-55. | CrossRef | PubMed
  26. Sommerfeld HJ, Meeker AK, Piatyszek MA, Bova GS, Shay JW, Coffey DS. Telomerase activity : A prevalent marker of malignant human prostate tissue. Cancer Res. 1996 Jan 1;56(1):218-22. | PubMed
  27. Mehle C, Piatyszek MA, Ljungberg B, Shay JW, Roos G. Telomerase activity in human renal cell carcinoma. Oncogene. 1996 Jul 4;13(1):161-6. | PubMed
  28. Tatsumoto N, Hiyama E, Murakami Y, Imamura Y, Shay JW, Matsura I,et al. High telomerase activity is an independent prognostic indicator of poor outcome in colorectal cancer. Clin Cancer Res. 2000 Jul;6(7):2696-701. | PubMed
  29. Shay JW, Gazdar AF. Telomerase in the early detection of cancer. J Clin Pathol. 1997 Feb;50(2):106-9. | CrossRef | PubMed
  30. Chong L, van Steensel B, Broccoli D, Erdjument-Bromage H, Hanish J, A human telomeric protein. Science. 1995 Dec 8;270(5242):1663-7. | CrossRef | PubMed
  31. Broccoli D, Smogorzewska A, Chong L, de Lange T. Human telomeres contain two distinct Myb – related protein, TRF1 and TRF2 . Nat Genet. 1997 Oct;17(2):231-5. | CrossRef | PubMed
  32. van Steensel B, Smogorzewska A, de Lange T. TRF2 protects human telomeres from end–to–end fusions. Cell. 1998 Feb 6;92(3):401-13. | CrossRef
  33. Bianchi A, Stansel RM, Fairall L, Griffith JD, Rhodes D, de Lange T. TRF1 binds a bipartite telomeric site with extreme spatial flexibility. EMBO J. 1999 Oct 15;18(20):5735-44. | CrossRef | PubMed
  34. Smith S, Giriat L, Schmitt A, de Lange T. Tankyrase a poly (ADP-ribose) polymerase at human telomeres. Science. 1998 Nov 20;282(5393):1484-7. | CrossRef | PubMed
  35. Smith S, de Lange T. Cell cycle dependent localization of the telomeric PARP, tankyrase, to nuclear pore complexes and centrosomes. J Cell Sci. 1999 Nov;112 (Pt 21):3649-56. | PubMed
  36. Bodnar AG, Ouelette M, Frolkis M, Holt SE, Chiu CP, Morin GB,et al. Extension of life – span by introduction of telomerase into normal human cells. Science. 1998 Jan 16;279(5349):349-52. | CrossRef | PubMed
  37. Weinrich SL, Pruzan R, Ma L, Ouelette M, Tesmer VM, Holt SE, et al. Reconstitution of human telomerase with the catalytic protein subunit hTRT. Nat Genet. 1997 Dec;17(4):498-502. | CrossRef | PubMed
  38. Engelhardt M, Ozkaynak MF, Drullinsky P, Sandoval C, Tugal O, Jayabose S,et al. Telomerase activity and telomere lengh in pediatric patients with malignancies undergoing chemotherapy. Leukemia. 1998 Jan;12(1):13-24. | CrossRef | PubMed
  39. Poremba C, Willenbring H, Hero B, Christiansen H, Schäfer KL, Brinkschmidt C,et al. Telomerase activity distinguishes between neuroblastomas with good and poor prognosis. Ann Oncol. 1999 Jun;10(6):715-21. | CrossRef | PubMed
  40. Poremba C, Scheel C, Hero B, Christiansen H, Schafer KL, Nakayama J,et al. Telomerase activity and telomerase subunits gene expresion patterns in neuroblastoma : a molecular and immunohistochemical study establishing prognostic tools for fresh – frozen and paraffin – embedded tissues. J Clin Oncol. 2000 Jul;18(13):2582-92. | PubMed
  41. Holt SE, Brown EJ, Zipursky A. Telomerase and the benign and malignant megakaryoblastic leukemias of Down syndrome. J Pediatr Hematol Oncol. 2002 Jan;24(1):14-7. | CrossRef | PubMed